Leave Feedback
Leave Feedback
HIV Watch Time: 50 mins

touchMDT From PrEP to long-term ART in HIV: Overcoming barriers to adherence throughout the journey

Key stakeholders discuss considerations for supporting adherence to PrEP and ART in people at risk of, or living with, HIV.

 Overview & Learning Objectives

Person at risk of, or living with, HIV
HIV Specialist and Clinical Pharmacist
Watch Video
Optimizing adherence to PrEP Dr Waters, Ms Marra

An HIV specialist and a clinical pharmacist discuss PrEP and how factors affecting adherence may be overcome in different populations at risk of HIV infection.

Watch Video
HIV Specialist, Specialist Nurse and Clinical Pharmacist
Watch Video
Assessing readiness to initiate ART Dr Waters, Ms Esteves, Ms Marra

Watch an HIV specialist, a specialist nurse and a clinical pharmacist discuss how they assess readiness to start ART and barriers to adherence.

Watch Video
HIV Specialist, Specialist Nurse and Advocate for PLHIV
Watch Video
Quality of life in PLHIV Dr Waters, Ms Esteves, Ms Cole

Watch an HIV specialist, a specialist nurse and an advocate for PLHIV discuss factors impacting quality of life and adherence to ART in PLHIV.

Watch Video
HIV Specialist, Specialist Nurse and Advocate for PLHIV
Watch Video
The relationship between PLHIV and HCPs Dr Waters, Ms Esteves, Ms Cole

Watch an HIV specialist, a specialist nurse and an advocate for PLHIV discuss the important role of the multidisciplinary team in optimizing adherence to ART and health of PLHIV.

Watch Video
HIV Specialist and Clinical Pharmacist

An HIV specialist and a clinical pharmacist discuss PrEP and how factors affecting adherence may be overcome in different populations at risk of HIV infection.
Expert Spotlight
Dr Laura Waters
Mortimer Market Centre, London, UK
Ms Fiona Marra
NHS Scotland, Glasgow, UK

Dr Laura Waters and Ms Fiona Marra consider how to increase PrEP awareness in populations at risk of HIV infection. They then discuss the importance of understanding individual needs to ensure adherence and the potential impact of long-acting injectable PrEP.

Listen on the Go

 Learn more Back to MDT Hub Time: 12:30
 
HIV Specialist, Specialist Nurse and Clinical Pharmacist

Watch an HIV specialist, a specialist nurse and a clinical pharmacist discuss how they assess readiness to start ART and barriers to adherence.
Expert Spotlight
Dr Laura Waters
Mortimer Market Centre, London, UK
Ms Catarina Esteves
Cascais Hospital, Cascais, Portugal
Ms Fiona Marra
NHS Scotland, Glasgow, UK

Dr Laura Waters, Ms Catarina Esteves and Ms Fiona Marra discuss the importance of assessing readiness to initiate life-long ART in individuals diagnosed with HIV infection and how to manage key barriers to ART adherence.

Listen on the Go

 Learn more Back to MDT Hub Time: 12:00
 
HIV Specialist, Specialist Nurse and Advocate for PLHIV

Watch an HIV specialist, a specialist nurse and an advocate for PLHIV discuss factors impacting quality of life and adherence to ART in PLHIV.
Expert Spotlight
Dr Laura Waters
Mortimer Market Centre, London, UK
Ms Catarina Esteves
Cascais Hospital, Cascais, Portugal
Ms Susan Cole
London, UK

Dr Laura Waters, Ms Catarina Esteves and Ms Susan Cole discuss factors impacting quality of life in ageing PLHIV, with an emphasis on non-communicable age-related comorbidities, pill burden and the role that long-acting injectable ART can play in improving adherence in certain patient populations.

Listen on the Go

 Learn more Back to MDT Hub Time: 13:20
 
HIV Specialist, Specialist Nurse and Advocate for PLHIV

Watch an HIV specialist, a specialist nurse and an advocate for PLHIV discuss the important role of the multidisciplinary team in optimizing adherence to ART and health of PLHIV.
Expert Spotlight
Dr Laura Waters
Mortimer Market Centre, London, UK
Ms Catarina Esteves
Cascais Hospital, Cascais, Portugal
Ms Susan Cole
London, UK

Dr Laura Waters, Ms Catarina Esteves and Ms Susan Cole discuss the importance of the relationship between PLHIV and members of the multidisciplinary team to overcome stigma and other barriers to adherence to ART.

Listen on the Go

 Learn more Back to MDT Hub Time: 11:50
 
Back To Top
Overview & Learning Objectives
Overview

In this activity, expert healthcare professionals (HCPs) who provide multidisciplinary care and support to people living with HIV (PLHIV), together with an advocate for PLHIV, discuss factors affecting initiation of and adherence to pre-exposure prophylaxis (PrEP) and antiretroviral therapy (ART) and how to improve the quality of life of ageing PLHIV.

Learning Objectives

After watching this activity, participants should be better able to:

  • Outline the factors leading to poor adherence to PrEP and how they can be overcome in clinical practice
  • Describe the challenges of ART initiation and adherence in newly diagnosed PLHIV and how to optimize monitoring and care of PLHIV
  • Discuss how care centred on the needs of PLHIV and new therapeutic approaches may improve overall quality of life and adherence to long-term ART in ageing adults living with HIV
Faculty & Disclosures
Dr Laura Waters

Mortimer Market Centre, London, UK

Dr Laura Waters is an HIV and sexual health consultant and HIV lead at the Mortimer Market Centre, London. read more

She is chair of the British HIV Association (BHIVA) and represents BHIVA on the HIV Clinical Reference Group, advising National Health System (NHS) England on HIV treatment and care. 

Dr Waters has published and presented widely and is a trustee for the Terrence Higgins Trust and The Food Chain. She teaches regularly at the local, regional and national level, including providing courses on HIV for University College London and the London School of Hygiene & Tropical Medicine.

Dr Laura Waters discloses: Consulting/advisory fees from Cipla, Gilead, Merck, Mylan, Theratech and ViiV Healthcare; Grants/research support from: Gilead, Merck and ViiV Healthcare; and Speaker fees from Gilead, Janssen, Merck, Mylan and ViiV Healthcare.

Ms Fiona Marra

NHS Scotland, Glasgow, UK

Ms Fiona Marra is a consultant pharmacist in infectious disease and hepatology, and lead clinician for the Scottish Paediatric & Adolescent Infection & Immunology Network for NHS Scotland. read more

She has a part-time academic appointment as principal pharmacist and is a member of the editorial board of the University of Liverpool, Drug Interactions websites. She sits on the committees of the BHIVA Hepatitis Group, the Scottish Malaria Group, the Joint Committee on Vaccination and Immunisation travel medicine sub-group, and is also co-chair of the Scottish Viral Hepatology Group. 

Ms Marra is a lead author of the European Guidelines (EASL) for hepatitis C virus (HCV) 2018 and 2020, has contributed to the World Health Organization guidelines in HIV 2021 and lectures globally on HIV and HCV drug interactions.

Ms Fiona Marra discloses: Educational grants and/or consultation fees from Gilead and ViiV Healthcare.

Ms Catarina Esteves

Cascais Hospital, Cascais, Portugal

Ms Catarina Esteves works as a specialist nurse in mental health and psychiatry and as study coordinator and paediatric transition nurse in the HIV Functional Unit at Cascais Hospital in Portugal. read more

She has been a member of the European HIV Nursing Networking (EHNN) since 2007 and formed a group of expert nurses in HIV to evaluate and standardize the role of the nurse in this area. She is an executive member of the Portuguese Association for the Study of AIDS.

Ms Esteves is an author on a number of publications on nursing in paediatric, adult and older adult populations living with HIV and also provides courses on these topics for audiences such as the Portuguese Council of Nurses.

Ms Catarina Esteves discloses: Consultancy and speaker fees from Gilead Sciences Lda and ViiV Healthcare.
Ms Susan Cole

London, UK

Ms Susan Cole is an award-winning HIV activist, broadcaster, writer and public speaker, who has been an advocate for people living with HIV for two decades. read more

She leads community engagement and broadcasting activities for the HIV information charity, NAM aidsmap, producing and hosting the live broadcast series aidsmapLIVE for a global audience of people living with HIV. 

Ms Cole is particularly passionate about issues affecting women and people of colour living with HIV, writing and presenting about the health inequities they face. She is a member of the Global HIV Collaborative, 4M Network of Mentor Mothers and serves as a community representative of the British Association for Sexual Health and HIV (BASHH) HIV Special Interest Group.

Ms Susan Cole has no interests/relationships or affiliations to disclose in relation to this activity.
Register to touchINFECTIOUS DISEASES for FREE
  • Peer-reviewed journals and expert opinions
  • Interactive CME and e-learning modules
  • Video conference highlights
Register For Free Now
This Activity Is Funded By:

An independent medical education grant from ViiV Healthcare UK Ltd. This activity is provided by touchIME.

Unapproved products or unapproved uses of approved products may be discussed by the faculty; these situations may reflect the approval status in one or more jurisdictions. The presenting faculty have been advised by touchIME to ensure that they disclose any such references made to unlabelled or unapproved use. No endorsement by touchIME of any unapproved products or unapproved uses is either made or implied by mention of these products or uses in touchIME activities. touchIME accepts no responsibility for errors or omissions.

This content is intended only for healthcare professionals.

Launch date: 4 April 2022.

This content is intended for healthcare professionals only. Please confirm that you are a healthcare professional.

Accept Decline
Feedback Close
Feedback

Please provide feedback for this touchMDT on the following
(scale 1-5, 1 strongly disagree; 5 strongly agree):

* = Mandatory Field

Feedback Close
Feedback

Thank you for your feedback.

Back to Activity
Copied to clipboard!
accredited arrow-down-editablearrow-downarrow_leftarrow-right-bluearrow-right-dark-bluearrow-right-greenarrow-right-greyarrow-right-orangearrow-right-whitearrow-right-bluearrow-up-orangeavatarcalendarchevron-down consultant-pathologist-nurseconsultant-pathologistcrosscrossdownloademailexclaimationfeedbackfiltergraph-arrowinterviewslinkmdt_iconmenumore_dots nurse-consultantpadlock patient-advocate-pathologistpatient-consultantpatientperson pharmacist-nurseplay_buttonplay-colour-tmcplay-colourAsset 1podcastprinter scenerysearch share single-doctor social_facebooksocial_googleplussocial_instagramsocial_linkedin_altsocial_linkedin_altsocial_pinterestlogo-twitter-glyph-32social_youtubeshape-star (1)tick-bluetick-orangetick-red tick-whiteticktimetranscriptup-arrowwebinar Sponsored Department Location NEW TMM Corporate Services Icons-07NEW TMM Corporate Services Icons-08NEW TMM Corporate Services Icons-09NEW TMM Corporate Services Icons-10NEW TMM Corporate Services Icons-11NEW TMM Corporate Services Icons-12Salary £ TMM-Corp-Site-Icons-01TMM-Corp-Site-Icons-02TMM-Corp-Site-Icons-03TMM-Corp-Site-Icons-04TMM-Corp-Site-Icons-05TMM-Corp-Site-Icons-06TMM-Corp-Site-Icons-07TMM-Corp-Site-Icons-08TMM-Corp-Site-Icons-09TMM-Corp-Site-Icons-10TMM-Corp-Site-Icons-11TMM-Corp-Site-Icons-12TMM-Corp-Site-Icons-13TMM-Corp-Site-Icons-14TMM-Corp-Site-Icons-15TMM-Corp-Site-Icons-16TMM-Corp-Site-Icons-17TMM-Corp-Site-Icons-18TMM-Corp-Site-Icons-19TMM-Corp-Site-Icons-20TMM-Corp-Site-Icons-21TMM-Corp-Site-Icons-22TMM-Corp-Site-Icons-23TMM-Corp-Site-Icons-24TMM-Corp-Site-Icons-25TMM-Corp-Site-Icons-26TMM-Corp-Site-Icons-27TMM-Corp-Site-Icons-28TMM-Corp-Site-Icons-29TMM-Corp-Site-Icons-30TMM-Corp-Site-Icons-31TMM-Corp-Site-Icons-32TMM-Corp-Site-Icons-33TMM-Corp-Site-Icons-34TMM-Corp-Site-Icons-35TMM-Corp-Site-Icons-36TMM-Corp-Site-Icons-37TMM-Corp-Site-Icons-38TMM-Corp-Site-Icons-39TMM-Corp-Site-Icons-40TMM-Corp-Site-Icons-41TMM-Corp-Site-Icons-42TMM-Corp-Site-Icons-43TMM-Corp-Site-Icons-44TMM-Corp-Site-Icons-45TMM-Corp-Site-Icons-46TMM-Corp-Site-Icons-47TMM-Corp-Site-Icons-48TMM-Corp-Site-Icons-49TMM-Corp-Site-Icons-50TMM-Corp-Site-Icons-51TMM-Corp-Site-Icons-52TMM-Corp-Site-Icons-53TMM-Corp-Site-Icons-54TMM-Corp-Site-Icons-55TMM-Corp-Site-Icons-56TMM-Corp-Site-Icons-57TMM-Corp-Site-Icons-58TMM-Corp-Site-Icons-59TMM-Corp-Site-Icons-60TMM-Corp-Site-Icons-61TMM-Corp-Site-Icons-62TMM-Corp-Site-Icons-63TMM-Corp-Site-Icons-64TMM-Corp-Site-Icons-65TMM-Corp-Site-Icons-66TMM-Corp-Site-Icons-67TMM-Corp-Site-Icons-68TMM-Corp-Site-Icons-69TMM-Corp-Site-Icons-70TMM-Corp-Site-Icons-71TMM-Corp-Site-Icons-72